JP2003246728A5 - - Google Patents

Download PDF

Info

Publication number
JP2003246728A5
JP2003246728A5 JP2002369185A JP2002369185A JP2003246728A5 JP 2003246728 A5 JP2003246728 A5 JP 2003246728A5 JP 2002369185 A JP2002369185 A JP 2002369185A JP 2002369185 A JP2002369185 A JP 2002369185A JP 2003246728 A5 JP2003246728 A5 JP 2003246728A5
Authority
JP
Japan
Prior art keywords
disease
animal
feed
salt
ornithine
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2002369185A
Other languages
English (en)
Japanese (ja)
Other versions
JP2003246728A (ja
Filing date
Publication date
Application filed filed Critical
Priority to JP2002369185A priority Critical patent/JP2003246728A/ja
Priority claimed from JP2002369185A external-priority patent/JP2003246728A/ja
Publication of JP2003246728A publication Critical patent/JP2003246728A/ja
Publication of JP2003246728A5 publication Critical patent/JP2003246728A5/ja
Pending legal-status Critical Current

Links

JP2002369185A 2001-12-21 2002-12-20 クロソ蛋白質発現量の減少により引きおこされる疾患の治療または予防剤 Pending JP2003246728A (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2002369185A JP2003246728A (ja) 2001-12-21 2002-12-20 クロソ蛋白質発現量の減少により引きおこされる疾患の治療または予防剤

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2001-389912 2001-12-21
JP2001389912 2001-12-21
JP2002369185A JP2003246728A (ja) 2001-12-21 2002-12-20 クロソ蛋白質発現量の減少により引きおこされる疾患の治療または予防剤

Publications (2)

Publication Number Publication Date
JP2003246728A JP2003246728A (ja) 2003-09-02
JP2003246728A5 true JP2003246728A5 (de) 2005-08-18

Family

ID=28677010

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2002369185A Pending JP2003246728A (ja) 2001-12-21 2002-12-20 クロソ蛋白質発現量の減少により引きおこされる疾患の治療または予防剤

Country Status (1)

Country Link
JP (1) JP2003246728A (de)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2007031375A (ja) * 2005-07-28 2007-02-08 Kyowa Hakko Kogyo Co Ltd 肌質改善用経口剤
JP2017019726A (ja) * 2015-07-07 2017-01-26 佐々木食品工業株式会社 Ｅｌｏｖｌ６阻害、ＮＡＳＨの予防又は治療並びにインスリン抵抗性改善用組成物
WO2021200996A1 (ja) * 2020-03-30 2021-10-07 味の素株式会社 骨強度低下の予防又は改善用組成物

Similar Documents

Publication Publication Date Title
MY176679A (en) Use of nutritional compositions for preventing disorders
EP3335710A3 (de) Verwendung von nährstoffzusammensetzungen zur vorbeugung von erkrankungen
SG135192A1 (en) Substituted pyrazoline compounds, their preparation and use as medicaments
IL219857A0 (en) Mitotic kinesin inhibitors, pharmaceutical compositions comprising them, uses thereof in the manufacture of a medicament for the treatment of disease or disorder in a human or animal that can be treated by inhibiting mitosis
WO2005047244A3 (en) Inhibition of fgfr3 and treatment of multiple myeloma
MXPA04005582A (es) Alimento o composicion de alimento para mascotas que contiene extracto de plantas para la salud osea.
WO2007022344A3 (en) Methods and compositions for the preventioin and treatment of kidney disease
JP2008500376A5 (de)
WO2020158632A1 (ja) 機能水
WO2009055799A3 (en) Compositions and methods for treatment of diseases of the foot of an animal
TW200510373A (en) Substituted quinolin-4-ylamine analogues
WO2005084401A3 (en) Aryl substituted purine analogues
WO2004110380A3 (en) Treatment of immune-mediated disorders with active vitamin d compounds alone or in combination with other therapeutic agents
WO2004093881A3 (en) Use of dipyridamole or mopidamole for treatment and prevention of thrombo-embolic diseases and disorders caused by excessive formation of thrombin and/or by elevated expression of thrombin receptors
ATE252847T1 (de) Gesunde hundefuttermittel
ATE409028T1 (de) Arzneien zur behandlung von nervenerkrankungen
TW200510308A (en) Isophthalic acid derivatives
WO2009061152A3 (en) Composition for prevention and treatment of pain containing curcumin or pharmaceutically acceptable salt thereof as an active ingredient
JP2003246728A5 (de)
MXPA05009242A (es) Tratamiento de la diabetes tipo 1 con los inhibidores de la pde5.
Motluk It's a wonderful lie
WO2004056768A3 (en) Use of substituted 2,5-diamidoindoles for the treatment of urological diseases
EP1550443A4 (de) Zusammensetzung gegen stressbedingte erkrankungen
HU0102987D0 (en) Pharmaceutical composition for treating parkinson's disease comprising astrocyte function-improving agent as active ingredient
WO2008075333A3 (en) Edible compositions for preventing hair loss